Aranucleosides and aranucleotides in viral chemotherapy.
D000818:Animals; D001087:Arabinonucleosides / Q000627:therapeutic use*; D001088:Arabinonucleotides / Q000627:therapeutic use*; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006564:Herpesviridae / Q000187:drug effects; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007042:Hypoxanthines / Q000627:therapeutic use; D013941:Thymine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014740:Vidarabine / Q000494:pharmacology / Q000627:therapeutic use; D001084:Vidarabine Phosphate / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication / Q000187:drug effects
D001087:Arabinonucleosides; D001088:Arabinonucleotides; D007042:Hypoxanthines; D003561:Cytarabine; D001084:Vidarabine Phosphate; D006147:Guanine; D014740:Vidarabine; D013941:Thymine